Patient and provider's perspective on barriers and facilitators for medication adherence among adult patients with cardiovascular diseases and diabetes mellitus in India: a qualitative evidence synthesis.
coronary heart disease
diabetes & endocrinology
preventive medicine
primary care
qualitative research
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
24 03 2022
24 03 2022
Historique:
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
13
4
2022
Statut:
epublish
Résumé
To explore the various stakeholders' perspectives on barriers and facilitators for medication adherence among patients with cardiovascular diseases (CVDs) and diabetes mellitus (DM)in India. Systematic review of qualitative studies. A comprehensive systematic search was conducted in Medline, Cochrane Library, Science Direct and Google Scholar from January 2010 to July 2020. We included all qualitative peer-reviewed studies, reporting barriers and facilitators of medication adherence, from India, for our current review. Data extraction was performed by two independent authors who also assessed the quality of included studies using the Critical Appraisal Skills Programme criteria. This qualitative evidence synthesis adhered to the enhancing transparency in reporting the synthesis of qualitative research checklist RESULTS: In total, 18 studies were included. Major barriers reported were lack of understanding about the disease, complications related to non-adherence, followed by forgetfulness, lack of family support and risk communication. Health system-related barriers such as accessibility, affordability and acceptability were also reported by majority of the studies. Creation of peer support groups, digital reminder systems, integration of native Indian systems of India, physiotherapy and geriatric clinics at the primary healthcare level and innovations in patient care were suggested to counter these barriers in medication adherence. Such patient-specific targeted interventions need to be developed to achieve better control among patients with CVD and DM.PROSPERO registration numberCRD42020199529.
Identifiants
pubmed: 35332041
pii: bmjopen-2021-055226
doi: 10.1136/bmjopen-2021-055226
pmc: PMC8948385
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e055226Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Int J Hypertens. 2019 Jan 23;2019:5749648
pubmed: 30809390
Adv Ther. 2005 Jul-Aug;22(4):313-56
pubmed: 16418141
BMC Fam Pract. 2021 May 22;22(1):99
pubmed: 34022811
J Am Coll Cardiol. 2017 Jan 31;69(4):437-451
pubmed: 28126162
J Family Med Prim Care. 2020 Jun 30;9(6):2830-2836
pubmed: 32984134
Indian J Community Med. 2018 Apr-Jun;43(2):72-76
pubmed: 29899603
BMJ Open. 2015 Sep 30;5(9):e008018
pubmed: 26423850
J Clin Epidemiol. 2018 Jul;99:41-52
pubmed: 29548841
J Hypertens. 2017 Dec;35(12):2346-2357
pubmed: 28777133
Indian J Community Med. 2020 Jul-Sep;45(3):315-319
pubmed: 33354010
J Family Med Prim Care. 2019 Feb;8(2):677-683
pubmed: 30984694
Ann Behav Med. 2013 Oct;46(2):237-42
pubmed: 23536121
Diabetes Educ. 1998 Jan-Feb;24(1):67-71
pubmed: 9526327
Glob Heart. 2018 Mar;13(1):27-34.e17
pubmed: 29146489
Indian Heart J. 2019 May - Jun;71(3):235-241
pubmed: 31543196
Glob Heart. 2019 Sep;14(3):303-310
pubmed: 31451238
BMJ Open. 2014 Sep 19;4(9):e005992
pubmed: 25239295
BMC Med Res Methodol. 2012 Nov 27;12:181
pubmed: 23185978
Front Pharmacol. 2017 Mar 01;8:100
pubmed: 28298894
J Patient Exp. 2019 Sep;6(3):216-223
pubmed: 31535010
Curr Cardiol Rep. 2019 Mar 4;21(4):21
pubmed: 30828746
BMC Public Health. 2019 Apr 16;19(1):409
pubmed: 30991978
Diabetes Res Clin Pract. 2011 Jul;93(1):1-9
pubmed: 21382643
Indian Heart J. 2016 May-Jun;68(3):278-85
pubmed: 27316478
BMC Health Serv Res. 2019 Mar 29;19(1):204
pubmed: 30925880
J Family Med Prim Care. 2019 Aug 28;8(8):2568-2572
pubmed: 31548933
BMJ Glob Health. 2019 Jan 25;4(Suppl 1):e000882
pubmed: 30775015
PLoS One. 2015 Sep 18;10(9):e0136202
pubmed: 26383535
J Family Med Prim Care. 2019 Dec 10;8(12):3773-3778
pubmed: 31879612
Lancet Glob Health. 2018 Dec;6(12):e1339-e1351
pubmed: 30219317
Can Pharm J (Ott). 2012 Mar;145(2):88-93
pubmed: 23509509
Res Social Adm Pharm. 2017 May - Jun;13(3):403-439
pubmed: 27432023
J Gen Intern Med. 2013 May;28(5):622-9
pubmed: 23307396
BMJ Open. 2018 Jan 23;8(1):e015332
pubmed: 29362241
Circulation. 1997 Feb 18;95(4):1085-90
pubmed: 9054774
Patient Prefer Adherence. 2016 Jul 22;10:1299-307
pubmed: 27524885
Expert Opin Drug Saf. 2014 Sep;13 Suppl 1:S41-55
pubmed: 25171158
Lancet Glob Health. 2018 Dec;6(12):e1352-e1362
pubmed: 30219315
Biomed Res Int. 2015;2015:217047
pubmed: 26539470
Value Health Reg Issues. 2018 May;15:12-26
pubmed: 29474174
J Clin Epidemiol. 2017 Aug;88:133-139
pubmed: 28433676
J Prim Care Community Health. 2019 Jan-Dec;10:2150132719865820
pubmed: 31375045